Relief of severe pulmonary hypertension after closure of a large ventricular septal defect using low dose inhaled nitric oxide
- 1 February 1993
- journal article
- case report
- Published by Springer Nature in Intensive Care Medicine
- Vol. 19 (2) , 75-77
- https://doi.org/10.1007/bf01708365
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newbornThe Lancet, 1992
- Inhaled nitric oxide in persistent pulmonary hypertension of the newbornThe Lancet, 1992
- Inhaled Nitric Oxide A Selective Pulmonary Vasodilator of Heparin-Protamine Vasoconstriction in SheepAnesthesiology, 1991
- MECHANISM OF INHIBITION OF EDRF SYNTHASE ACTIVITY BY HIGH AND LOW OXYGEN TENSIONSAnesthesiology, 1991
- Nitric oxide: physiology, pathophysiology, and pharmacology.1991
- Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.Circulation, 1991
- Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein.Circulation Research, 1989
- The discovery of nitric oxide as the endogenous nitrovasodilator.Hypertension, 1988
- Endothelium-derived relaxing factorBiochemical Pharmacology, 1988
- Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.Proceedings of the National Academy of Sciences, 1987